Home/Filings/4/0001144204-18-040247

4//SEC Filing

Sohail Faysal A. 4

Accession 0001144204-18-040247

CIK 0001566044other

View on SEC.gov Company Profile

Filed

Jul 25, 8:00 PM ET

Accepted

Jul 26, 7:11 PM ET

Size

17.4 KB

Accession

0001144204-18-040247

Insider Transaction Report

Form 4

Period: 2018-07-24

Menlo Therapeutics Inc.MNLO

CMEA Ventures VII LP

10% Owner

Transactions

Sale
Common Stock
2018-07-24$7.65/sh−487,500$3,729,375→ 1,907,568 total(indirect: By Presidio Partners 2007, L.P.)
Sale
Common Stock
2018-07-24$7.65/sh−12,500$95,625→ 48,910 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)

Holdings

Common Stock
(indirect: By David J. Collier)
152,062

Presidio Partners 2007 GP, L.P.

10% Owner

Transactions

Sale
Common Stock
2018-07-24$7.65/sh−487,500$3,729,375→ 1,907,568 total(indirect: By Presidio Partners 2007, L.P.)
Sale
Common Stock
2018-07-24$7.65/sh−12,500$95,625→ 48,910 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)

Holdings

Common Stock
(indirect: By David J. Collier)
152,062

CMEA VENTURES VII (PARALLEL) LP

10% Owner

Transactions

Sale
Common Stock
2018-07-24$7.65/sh−487,500$3,729,375→ 1,907,568 total(indirect: By Presidio Partners 2007, L.P.)
Sale
Common Stock
2018-07-24$7.65/sh−12,500$95,625→ 48,910 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)

Holdings

Common Stock
(indirect: By David J. Collier)
152,062

Collier David J

10% Owner

Transactions

Sale
Common Stock
2018-07-24$7.65/sh−487,500$3,729,375→ 1,907,568 total(indirect: By Presidio Partners 2007, L.P.)
Sale
Common Stock
2018-07-24$7.65/sh−12,500$95,625→ 48,910 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)

Holdings

Common Stock
(indirect: By David J. Collier)
152,062

Sohail Faysal A.

10% Owner

Transactions

Sale
Common Stock
2018-07-24$7.65/sh−487,500$3,729,375→ 1,907,568 total(indirect: By Presidio Partners 2007, L.P.)
Sale
Common Stock
2018-07-24$7.65/sh−12,500$95,625→ 48,910 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)

Holdings

Common Stock
(indirect: By David J. Collier)
152,062

Watson James F

10% Owner

Transactions

Sale
Common Stock
2018-07-24$7.65/sh−487,500$3,729,375→ 1,907,568 total(indirect: By Presidio Partners 2007, L.P.)
Sale
Common Stock
2018-07-24$7.65/sh−12,500$95,625→ 48,910 total(indirect: By Presidio Partners 2007 (Parallel), L.P.)

Holdings

Common Stock
(indirect: By David J. Collier)
152,062

Footnotes (3)

[F1]Securities directly held by Presidio Partners 2007, L.P. ("Presidio Partners"). Presidio Partners 2007 GP, L.P. ("Presidio GP") is the sole general partner of Presidio Partners. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio GP, and may be deemed to have voting control and investment power over the securities held by Presidio Partners, but disclaim beneficial ownership of the securities held by Presidio Partners, except to the extent of their pecuniary interest therein.
[F2]Securities directly held by Presidio Partners 2007 (Parallel), L.P. ("Presidio Parallel"). Presidio GP is the sole general partner of Presidio Parallel. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio Parallel, and may be deemed to have voting control and investment power over the securities held by Presidio Parallel, but disclaim beneficial ownership of the securities held by Presidio Parallel, except to the extent of their pecuniary interest therein.
[F3]Securities directly held by David J. Collier, M.D.

Documents

1 file

4
tv499325_4.xmlPrimary
FORM 4

Issuer

Menlo Therapeutics Inc.

CIK 0001566044

→

Entity typeother

Related Parties

filerCIK 0001425394

Filing Metadata

Form type: 4
Filed: Jul 25, 8:00 PM ET
Accepted: Jul 26, 7:11 PM ET
Size: 17.4 KB

View on SEC.gov